Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism
Arteriosclerosis, thrombosis, and vascular biology, 2018-07, Vol.38 (7), p.1644-1655 [Peer Reviewed Journal]2018 American Heart Association, Inc. ;2018 American Heart Association, Inc. 2018 ;ISSN: 1079-5642 ;EISSN: 1524-4636 ;DOI: 10.1161/ATVBAHA.118.310882 ;PMID: 29880491
Full text available